Showing results (111-120 of 154) with videos related to
Sort By:
Pageof 16
Journal of Clinical Lipidology|December 3, 2010
Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patientsJoAnne M Foody, Shiva G Sajjan, X Henry Hu, et al.Antimicrobial Agents and Chemotherapy|May 1, 1996
A novel antiviral agent which inhibits the endonuclease of influenza virusesJ E Tomassini, M E Davies, J C Hastings, et al.Journal of Clinical Lipidology|March 6, 2012
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reductionPeter P Toth, Christie M Ballantyne, Michael H Davidson, et al.The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.Journal of Clinical Lipidology|July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndromeJennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.Journal of Clinical Lipidology|February 18, 2014
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular diseasePeter P Toth, Joanne M Foody, Joanne E Tomassini, et al.Atherosclerosis|August 6, 2016
Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practiceAlberico L Catapano, Dominik Lautsch, Lale Tokgözoglu, et al.The American Journal of Cardiology|October 21, 2016
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic HypercholesterolemiaPeter P Toth, Alberico L Catapano, Michel Farnier, et al.Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.Journal of Natural Products|August 24, 2002
Durhamycin A, a potent inhibitor of HIV Tat transactivationHiranthi Jayasuriya, Russell B Lingham, Pia Graham, et al.Pageof 16